Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 24-25
© 2002 European Renal Association-European Dialysis and Transplant Association

SECTION II: Haemodialysis adequacy

II.4 Monitoring of treatment

Abstract

Guideline II.4.1

A. Indices used to quantify the efficiency of HD depend upon the blood urea concentration in pre- and post-HD blood samples. Therefore, it is crucial that these samples be taken carefully with a standard method.

(Evidence level: A)

Guideline II.4.2

A. The delivered dose of HD should be checked at least monthly.

(Evidence level: B)

B. Renal function may only be included in the assessment if it is measured monthly at the same time as the delivered dose of HD. Because renal function may change over time, historic renal function data may not be used.

Guideline II.4.3

A. If a patient fails to receive the adequate HD dose, or if a significant difference between the prescribed and the delivered dose is observed, a search for the cause of the problem must be undertaken.

(Evidence level: B)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
J. C. Korevaar, J. G. van Manen, F. W. Dekker, D. R. de Waart, E. W. Boeschoten, R. T. Krediet, and for the NECOSAD Study Group
Effect of an Increase in C-Reactive Protein Level during a Hemodialysis Session on Mortality
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2916 - 2922.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.